RAS G12D-mutated NSCLC trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All RAS G12D-mutated NSCLC trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
  NCT06162221 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.